Total planned funding: $709,744,056
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $709,744,056 |
Organizational Types
NGO | $250,561,810 |
Private Contractor | $164,509,733 |
University | $83,662,140 |
Own Agency | $73,746,445 |
Implementing Agency | $59,955,512 |
Unknown | $55,216,417 |
FBO | $21,175,999 |
Other USG Agency | $916,000 |
Multi-lateral Agency | $0 |
Host Country Government Agency | $0 |
Program Areas
Treatment | $257,045,962 |
Prevention | $177,197,322 |
Care | $155,389,622 |
Testing | $46,577,638 |
Management and Operations | $41,682,198 |
Governance and Systems | $31,851,314 |
Budget Codes
HTXS: Treatment: Adult Treatment | $161,405,136 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $112,847,131 |
HKID: Care: Orphans and Vulnerable Children | $86,699,127 |
HTXD: Treatment: ARV Drugs | $84,100,264 |
HVCT: Testing: HIV Testing and Counseling | $46,577,638 |
HVMS: Management and Operations | $41,682,198 |
HVOP: Sexual Prevention: Other Sexual Prevention | $40,247,665 |
HBHC: Care: Adult Care and Support | $32,477,072 |
HVTB: Care: TB/HIV | $22,828,794 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,062,679 |
PDCS: Care: Pediatric Care and Support | $13,384,629 |
HVSI: Strategic Information | $13,032,985 |
OHSS: Health Systems Strengthening | $12,673,703 |
PDTX: Treatment: Pediatric Treatment | $11,540,562 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,039,847 |
HLAB: Laboratory Infrastructure | $6,144,626 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Chemonics International:
$127,923,922
Countries/Regions
University of Washington:
$106,196,755
Countries/Regions
FHI 360:
$53,072,198
Countries/Regions